Format

Send to

Choose Destination
See comment in PubMed Commons below
Trends Immunol. 2004 Oct;25(10):543-50.

Molecular interactions regulate BCR signal inhibition by CD22 and CD72.

Author information

1
Institute for Virology and Immunobiology, University of Würzburg, Versbacherstr.7, 97078 Würzburg, Germany. nitschke@vim.uni-wuerzburg.de <nitschke@vim.uni-wuerzburg.de>

Abstract

The inhibitory coreceptors CD22 and CD72 downmodulate B-cell receptor (BCR) signaling and function as a molecular switch, determining whether antigen-stimulated B cells undergo apoptosis or proliferation. These coreceptors carry an intrinsic property for associating with the BCR, and this association is crucial for the initiation of signal inhibition through phosphorylation of these coreceptors by BCR-associated kinases. Recent findings have demonstrated that signal inhibition by these coreceptors is regulated by ligands for the coreceptors and by molecules binding to the coreceptors or the BCR. Moreover, signal inhibition by CD22 depends on the BCR isotype. These findings suggest a dynamic regulation of these coreceptors through molecular interactions on the B-cell surface.

PMID:
15364057
DOI:
10.1016/j.it.2004.08.002
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center